Navigation Links
David Kahal Joins AXA Equitable as National Sales Manager
Date:10/16/2007

To Lead Life Insurance Wholesaling to Company's Retail Distribution Channel

NEW YORK, Oct. 16 /PRNewswire-FirstCall/ -- David Kahal has joined AXA Equitable as National Sales Manager for its life insurance wholesale organization headquartered in Farmington, CT. The announcement was made today by Jamie Shepherdson, Executive Vice President and head of the company's life and annuity wholesale distribution organization. Mr. Kahal will report to Marian Sole, Senior Vice President.

Mr. Kahal is responsible for leading the wholesale distribution, sales and business development of AXA Equitable life insurance products to AXA Advisors, LLC -- the company's retail network of approximately 6,000 financial professionals nationwide. His focus is on helping AXA Advisors financial professionals grow their business through life insurance product education, coaching, sales support and service. Mr. Kahal leads a team of 11 wholesalers.

For Mr. Kahal, the appointment marks a return to AXA, where he spent almost eight years as a District Manager and financial professional with AXA Advisors. From 1998 to 2003, he was a National Sales Manager, during which time he piloted the company's initial life insurance wholesaling efforts.

"Dave has a keen understanding of the AXA Advisors retail structure and is widely known for his coaching skills and successful consultative and service approach to sales," said Ms. Sole. "His appointment reinforces the company's commitment to providing focused sales support for our financial professionals."

Previously, Mr. Kahal was Senior Vice President, National Sales Manager with LifeSource/Time Financial, a BISYS company. He was a co-founder and owner of LifeSource Executive Benefits and Insurance Service, a specialized brokerage general agency focused on distribution to wirehouses and regional broker dealers.

Mr. Kahal earned a bachelor's degree from San Diego State University. He holds FINRA Series 7 and 63 licenses.

About AXA Equitable

AXA Equitable Life Insurance Company, New York, N.Y., has been in business since 1859 and is a leading nationwide issuer of life insurance and annuity products. The company has over 11,000 employees and sales personnel and approximately 4.8 million policy/contract holders nationwide as of December 31, 2006.

AXA Equitable is one of the premier U.S. organizations providing life insurance and annuity products and services for the financial services market. Variable products are co-distributed by affiliates AXA Advisors, LLC, and AXA Distributors, LLC.

AXA Equitable proprietary life insurance products are marketed on a wholesale basis primarily to brokerage general agents (BGAs), broker/dealers, independent financial planner producer groups, as well as the AXA Advisors, LLC retail distribution network of financial professionals.

These products include Athena Universal Life and Athena Survivorship Life, Incentive Life (IL) Series, including IL Legacy and IL Survivorship and the AXA Equitable Level Term and Return of Premium Term Series.

AXA Equitable's parent company, AXA Financial, Inc., is a member of the global AXA Group, a worldwide leader in financial protection and wealth management. AXA Group's operations are diverse geographically, with major operations in Western Europe, North America, and the Asia/Pacific region. The AXA ordinary share is listed on the Paris Stock Exchange and trades under the symbol AXA. The AXA American Depositary Share is also listed on the NYSE under the ticker symbol AXA. AXA Equitable is solely responsible for its life insurance and annuity obligations.

We invite you to visit us at http://www.axa-equitable.com


'/>"/>
SOURCE AXA Equitable
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. The Emotional Side of David Beckham Revealed
2. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
3. Rat joins list of cloned animals
4. Richard Gere Joins Indian Stars For Fight Against AIDS
5. Enbrel Joins with Methotrexate to Cure Rheumatoid Arthritis
6. Anoushka Joins Hands With WFP to Feed the Poor
7. India Joins Hands With Global Body for Vaccine Research
8. Another Statewide Organization Joins the Fight Against Assisted Suicide
9. Two-year-old Joins Mensa, Becomes Its Youngest Ever Genius
10. International community warns India on HIV situation
11. Mexico and US border attain a new outlook due to BiNational Sustainability Laboratory
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... As renowned, board-certified dermatologists, Dr. Sabrina G. Fabi ... patients who do not do their research and undergo cosmetic dermatology treatments from unqualified ... midst of a renaissance and every other month a new treatment or device is ...
(Date:12/5/2016)... , ... December 05, 2016 , ... ... today that they have teamed up with The American College of Surgeons (ACS) ... ACS’s Committee on Trauma, the “Bleeding Control Basic” course is a pilot program ...
(Date:12/4/2016)... (PRWEB) , ... December 03, 2016 , ... ... organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community ... hosted its first Swirl: A Wine Tasting Event in New York City, with ...
(Date:12/4/2016)... ... December 03, 2016 , ... Houston ... the 2016 Anti-Aging & Beauty Awards at The Aesthetic & Anti-aging Medicine ... Medicine European Congress (AMEC) brings together the industry’s leading scientific experts, speakers, ...
(Date:12/4/2016)... (PRWEB) , ... December 04, 2016 , ... ... undergoing major cosmetic surgery can now take advantage of a cosmetic procedure known ... skin rejuvenation treatment that reduces the appearance of age spots, fine lines, ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... December 5, 2016 PharmaBoardroom today releases its new ... ... This report offers companies, investors, policymakers, and stakeholders crucial insight into ... Europe , home to some of the world,s most important ... in Novartis and Roche, and with a number one ranking globally in ...
(Date:12/4/2016)... CAMBRIDGE, Mass. , Dec. 4, 2016 /PRNewswire/ ... a leader in discovering and developing targeted kinase ... announced data from its ongoing Phase 1 trial ... of patients with advanced systemic mastocytosis (SM). Blueprint ... selective inhibitor of D816V mutant KIT. Approximately 90 ...
(Date:12/4/2016)... Dec. 3, 2016 Sickle cell disease (SCD) ... red blood cells that get stuck in veins and ... organ failure, and complications leading to death. Each year, ... SCD, and most of them lack access to comprehensive ... established long-term therapy for SCD, a pill called hydroxyurea ...
Breaking Medicine Technology: